检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘莹[1] 刘楠启[1] 王国丽[1] 韩龙[2] 孟胜男[2]
机构地区:[1]中国医科大学基础医学院生物化学教研室,辽宁沈阳110001 [2]中国医科大学药学院药剂学教研室,辽宁沈阳110001
出 处:《药物生物技术》2013年第5期381-385,共5页Pharmaceutical Biotechnology
基 金:国家自然科学基金(No.81173123)
摘 要:将6个月不同性别的C57BL/6小鼠分为雌、雄两组(n=6),分别取其肝脏,以荧光定量PCR(Real time quantitative PCR,RT-qPCR)测定肝脏中I相代谢酶mRNA的相对表达量。在分析的24个I相代谢酶中有8个代谢酶(Cyp2b9、Cyp4a14、Cyp2b10、Cyp2b13、Cyp4a10、Cyp2c38、Fmo3、Nqo1)的mRNA水平在雌性小鼠肝脏中高表达(P<0.01或P<0.05);5个代谢酶(Cyp4a12、Cyp7b1、Cyp2d9、Fmo5、Cess2c)的mRNA水平在雄性小鼠肝脏中表达较高(P<0.01或P<0.05);其它I相代谢酶在雌雄小鼠肝脏中的mRNA表达没有显著性差异。研究显示,性别差异显著影响小鼠肝脏中I相代谢酶的mRNA表达谱,这将导致药物在药动学和药效学方面的个体差异。Sex-based differences in drug metabolism are the primary cause of sex-dependent pharmacokinetics and reflect underlying gender differences in the expression of hepatic enzymes active in the metabolism of drugs. To reveal the possible molecular mecha- nisms of altered xenobiotic disposition and toxicity in individuals, mRNA profiles for phase I metabolizing enzymes were characterized in livers of male and female mice of 6 months of age. C57BL/6 mice were randomly divided into female group and male group (n = 6), and the livers were collected. The relative mRNA expression of phase I metabolizing enzymes was examined by real time quantitative PCR ( RT-qPCR ) . Sex-based differences were investigated for 24 phase I metabolizing enzymes, and gender differences were observed. In female and male mice, mRNA levels for 8 phase I metabolizing enzymes ( e. g. , Cyp2b9, Cyp4al4, Cyp2bl0, Cyp2bl 3, Cyp4al0, Cyp2c38, Fmo3, Nqol ) were higher in female mice ( P 〈 O. 01 or P 〈 0.05 ) ,whereas mRNA levels for 5 phase I metabo- lizing enzymes (e. g. , Cyp4al2, Cyp7bl, Cyp2d9, FmoS, Cess2c) were higher in male mice ( P 〈 0. 01 or P 〈 0.05 ). The mRNA levels for left enzymes ( Cypl al, Cyp2a4, Cyp2a5, Cyp3a41, Fmol, Cess3a, Por, Adh4, Aldh3a2, Aldh4al and Aldh6al ) showed the similar levels in both genders. Gender differences have significant effects on the mRNA expression profiles of phase I metabolizing enzymes in livers of mice, and it may characterize pharmacokinetics and pharmacodynamics of drugs and contribute to individual differences in drug efficacy and toxicity.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.222.132.108